In this study, we investigated (i) if 3q amplification in precancerous and cancerous cervical lesions targets SEC62 as potential 3q encoded oncogene, (ii) if the dysplastic cervical cells show a corresponding overexpression of the SEC62 gene and (iii) if SEC62 had an oncogenic function in cultured cervical cancer cells through altering cell migration, cell proliferation and EMT induction. The gene discussed is SEC62; the disease is cervical carcinoma.